Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New monitor could speed up treatment of low blood pressure during labor epidurals

NCT ID NCT05906368

Knowledge-focused Sponsor: Grace Lim, MD, MS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a new blood pressure monitor (ClearSight HPI) in 34 healthy pregnant women receiving epidural pain relief during labor. The goal was to see if the device helps nurses detect and treat low blood pressure faster than standard monitoring. The study focused on feasibility and ease of use, not on proving the device works better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ClearSight HPI Monitoring system
What this could lead to
If successful, this device could help doctors treat low blood pressure faster during labor epidurals, improving safety and comfort for mothers.
What could go wrong
This is a small pilot study with only 34 participants, so results may not apply to all women. The device's real-world benefit is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Apr 2024

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant * Age ≥ 18 years of age * Planning vaginal delivery * Receiving epidural labor analgesia (ELA) Exclusion Criteria: * Non-reassuring fetal tracing at the time of ELA request * Contraindications to ELA * Significant cardiac arrhythmias or aortic regurgitation * Arrhythmia * Treatment with antihypertensive medications * Pre-eclampsia with or without severe features * Preoperative infection * Inability to use ClearSight device for any reason * Non-English fluency * Sustains unintentional dural puncture * Incomplete data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia, epidural are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypotensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anesthesia, epidural Hypotension

Contacts and locations

Locations

  • Magee Womens Hospital of UPMC

    Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.